Julie Freed Lab
Julie Freed, MD, PhDAssistant Professor, Department of Anesthesiology
Dr. Freed’s research primarily focuses on the role that sphingolipids have in the development of endothelial dysfunction in the human microcirculation. Elevated plasma levels of ceramide, a prototypical sphingolipid, is now considered an independent risk factor for major adverse cardiovascular events in otherwise healthy people. The Freed lab is currently investigating how these bioactive lipids are regulated in human endothelial cells.
As a cardiac anesthesiologist, Dr. Freed is also interested in intraoperative blood pressure control including mechanisms and treatments of vasoplegia. Other interests include translating her work in the lab to improve outcomes for surgical patients.
Research Technologist II
Her primary responsibility is to analyze vascular reactivity of human coronary arterioles and adipose microvessels to help elucidate differences in healthy vs. diseased vasculature. Specifically, she is investigating mediators that control the switch from a healthy vascular dilation response (nitric oxide) to a pro-inflammatory vascular dilation response (hydrogen peroxide). Mary is also studying novel treatments for bacterial-induced vasoplegia. Additionally, she manages the purchasing and budgeting, among other administrative responsibilities.
Kelsey graduated from the University of California, Davis with a Bachelor’s degree in Genetics in 2013. Prior to starting at MCW she spent a year in India doing public health research with the Center for Disease Dynamics Economics and Policy, and spent two years coordinating clinical trials for lymphoma treatments at Stanford’s Medical Center. She is currently a medical student in the class of 2020 at MCW.
In the Freed lab she is studying the mechanism behind hydroxocobalamin’s (Vitamin B12) treatment of vasoplegia, a state of refractory hypotension despite normal or high cardiac output. She is passionate about her work in Dr. Freed’s lab because of its direct application to clinical practice.
(Pagel PS, Freed JK, Lien CA.) J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3229-3234 PMID: 31412981 SCOPUS ID: 2-s2.0-85070355320 08/16/2019
(Patel JJ, Venegas-Borsellino C, Willoughby R, Freed JK.) Nutr Clin Pract. 2019 Aug;34(4):514-520 PMID: 31187494 SCOPUS ID: 2-s2.0-85067343132 06/13/2019
(Pagel PS, Freed JK, Lien CA.) J Cardiothorac Vasc Anesth. 2019 03;33(3):593-599 PMID: 30638921 SCOPUS ID: 2-s2.0-85059613187 01/15/2019
(Freed JK.) Circ Res. 2019 01 04;124(1):15-17 PMID: 30605409 SCOPUS ID: 2-s2.0-85059495332 01/04/2019
(Freed JK, Durand MJ.) Am J Physiol Heart Circ Physiol. 2018 09 01;315(3):H632-H633 PMID: 29906230 SCOPUS ID: 2-s2.0-85052948336 06/16/2018
Advanced Age Attenuates Left Ventricular Filling Efficiency Quantified Using Vortex Formation Time: A Study of Octogenarians With Normal Left Ventricular Systolic Function Undergoing Coronary Artery Surgery.
(Pagel PS, Dye L 3rd, Boettcher BT, Freed JK.) J Cardiothorac Vasc Anesth. 2018 08;32(4):1775-1779 PMID: 29525195 SCOPUS ID: 2-s2.0-85042941834 03/12/2018
(Dye L 3rd, Freed JK, Leschke JR, Pagel PS.) J Cardiothorac Vasc Anesth. 2018 08;32(4):2031-2033 PMID: 29196139 SCOPUS ID: 2-s2.0-85035239514 12/03/2017
(Freed JK, Simon JA, Iqbal Z, Almassi GH, Pagel PS.) J Cardiothorac Vasc Anesth. 2018 06;32(3):1529-1532 PMID: 28927695 SCOPUS ID: 2-s2.0-85029484659 09/21/2017
(Zundel MT, Feih JT, Rinka JRG, Boettcher BT, Freed JK, Kaiser M, Ghadiali HY, Tawil JN, Woehlck HJ, Pagel PS.) J Cardiothorac Vasc Anesth. 2018 02;32(1):452-457 PMID: 28778773 SCOPUS ID: 2-s2.0-85026519109 08/06/2017
(Pagel PS, Freed JK, Lien CA.) Scientometrics. 2019 SCOPUS ID: 2-s2.0-85069887802 01/01/2019
(Pagel PS, Dye L 3rd, Hill GED, Vega JL, Tawil JN, De Vry DJ, Chandrashekarappa K, Iqbal Z, Boettcher BT, Freed JK.) J Vis Exp. 2018 11 28(141) PMID: 30582607 SCOPUS ID: 2-s2.0-85058138415 12/26/2018
(Pagel PS, Freed JK.) Kaplan's Essentials of Cardiac Anesthesia for Cardiac Surgery. 6 December 2017:62-79 SCOPUS ID: 2-s2.0-85054465241 12/06/2017